Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q61163207)
Watch
English
Clinical Approval Success Rates for Investigational Cancer Drugs
scientific article published on 05 June 2013
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
title
Clinical approval success rates for investigational cancer drugs
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author
Janice M. Reichert
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
author name string
J A DiMasi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
L Feldman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
A Malins
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
language of work or name
English
0 references
publication date
5 June 2013
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
published in
Clinical Pharmacology & Therapeutics
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
volume
94
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
page(s)
329-335
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
cites work
Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost of innovation in the pharmaceutical industry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The price of innovation: new estimates of drug development costs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Success rates in the United States drug development system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Success rates for new drugs entering clinical testing in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risks in new drug development: approval success rates for investigational drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can the pharmaceutical industry reduce attrition rates?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biopharmaceuticals and conventional drugs: clinical success rates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant protein and therapeutic monoclonal antibody drug development in the United States from 1980 to 1994
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoclonal antibodies as innovative therapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trends in risks associated with new drug development: success rates for investigational drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FCLPT.2013.117
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/CLPT.2013.117
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
PubMed publication ID
23739536
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23739536
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739536%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit